Nuclear Medicine in Oncology

1. Front Matter

   Pages i-xi

   PDF

2. Glucose Metabolism Imaging

   • Liang Shi, Jianjun Liu

   Pages 1-10

3. Clinical Utility of PET/CT in Breast Cancer Management and Targeted Therapy

   • Xinzhong Hao, Xiaxia Meng, Zhifang Wu

   Pages 11-24

4. Using 18F-FDG PET/CT to Diagnose and Treat Non-small Cell Lung Cancer

   • Liu Liu, Maomei Ruan, Wenhui Xie

   Pages 25-45

5. Clinical Application of 18F-FDG PET/CT in Lymphoma

   • Xiaoli Lan, Altine Bouhari, Khamis Hassan Bakari, Alexandre Niyonkuru

   Pages 47-59

6. Clinical Utility of 18F-FDG PET/CT Scanning in Urological Cancers Management

   • Xiang Zhou, Gang Huang

   Pages 61-75

7. Gynecologic Tumor PET/CT Imaging

   • Qian Xia, Gang Huang

   Pages 77-86

8. Molecular Imaging and Targeted Therapy of Gastrointestinal Cancer

   • Menghui Yuan, Hua Pang

   Pages 87-99

9. Head and Neck Cancer

   • Hubing Wu, Shaoli Song

   Pages 101-127

10. Molecular Imaging and Targeted Therapy for Malignant Melanoma

    • Bin Zhang

    Pages 129-138

11. Role of 18F-FDG PET/CT in Pediatric Oncology

    • Hongliang Fu, Suyun Chen, Hui Wang

    Pages 139-152

12. Molecular Imaging

    • Hubing Wu, DeWei Tang, XiaoPing Zhao, Gengbiao Yuan, Xinhui Su

    Pages 153-176

13. Receptor-Targeted Radionuclide Imaging (RTRI) and Peptide Receptor Radionuclide Therapy (PRRT)

    • Weidong Yang, Cheng Wang, Gang Huang

    Pages 177-199

14. Radioimmunoimaging and Targeted Therapy

    • Yafu Yin, Steven Rowe

    Pages 201-214

15. Apoptosis Imaging

    • Hui Wang, Xiao-Jun Zhang

    Pages 215-223

16. Radionuclide Gene and Reporter Gene Imaging

    • Xiaoli Lan, Min Ye, Pengxin Qiao, Wenxia Wang

    Pages 225-233

17. Na+/I− Symporter Target for Thyroid Disease Imaging and Treatment

    • Rui Huang, Rong Tian, Zhaowei Meng

    Pages 235-255

18. Molecular Imaging and Targeted Therapy in Neurology

    • Qian Xu, Weishan Zhang, Chuantao Zuo

    Pages 257-266

19. Nuclear Cardiology

    • Xu Cheng

    Pages 267-295

20. Equipment for Imaging and Mechanism of Radiation Protection

    • Rui Li, Qiang Jia, Zhaowei Meng, Shen Wang, Ruiguo Zhang, Wensen Jin et al.

    Pages 297-314

This book introduces molecular imaging and Target Therapy in various cancers. The first part is the subjects and primary focused on the basics of nuclear physics, radiation dosimetry, nuclear medicine equipment and small animal imaging equipment. The second part is about the radiopharmaceutical and commonly used clinical radiopharmaceuticals, including positron emission imaging agent, single photon emission imaging agent, and radionuclide therapy agents as well as their radioactive preparation, quality control, and a brief clinical application were included. Also, this part introduces a number of new imaging agents which were potential value of clinical applications. In the third part, the clinical application of the conventional imaging agent 18F-FDG in different tumors and neurodegenerative diseases and 18F-Dopa imaging in the nervous system are discussed. Besides the clinical applications of 99mTc labeled radiopharmaceuticals in parathyroid disease, coronary heart disease, myocardial infarction, sentinel lymph node, metastatic bone tumors, liver and gallbladder disease in children are introduced. Finally, the applications of radionuclide 131I on treatments of Graves' disease and differentiated thyroid cancer and metastases are investigated respectively.

This book is a useful reference for professionals engaged in nuclear medicine and clinical research, including clinical nuclear medicine physicians, nuclear medicine engineers and nuclear medicine pharmacists.

• SPECT
• PET/CT
• PET/MRI
• 99mTc
• 131I
• 18F
• 11C

• Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China

  Gang Huang

Editor Gang Huang is a professor and the President, Shanghai University of Medicine & Health Sciences(SUMHS). He is also the Elected President of Asia-Oceanian Federation of Nuclear Medicine &Biology; Dean of Asia School of Nuclear Medicine; Editor in Chief, Chinese Journal of Nuclear Medicine & Molecular Imaging andt the predecessor president of Chinese Society of Nuclear Medicine.

Policies and ethics